2LASKUS T,RADKOWSKI M,WANG LF,et al. Search for hepatitis C virus extrahepatic replication site in patients with acquired immunodeficiency syndrome:specific detection of negative strand viral RNA in tissue [J]. Hepotology, 1998,28 : 1398.
3SIMO R,LECUBE A,GENESCA J,et al. Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection[J]. Diabetes Care,2006,29.2462-2466.
4KONRAD T,ZEUZEM S,VICINI P,et al. Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-alpha[J]. Eur J Clin Invest, 2000,30 : 111-121.
5LO IACONO O,VENEZIA G,PETrA S,et al. The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C[J]. Aliment Pharmacol Ther, 2007,25 : 113.
3Tak PP, ten Kate FJ. Remission of active diabetic hepatitis after correction of hyperglycemia. Liver, 1993,13 ( 4 ) : 183-187.
4Holstein A, Hinze S, Thiessen E, et al. Clinical implications of hepatogenous diabetes in liver cirrhosis. J Gastroenterol Hepatol, 2002,17(6) :6774581.
5Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 2003,26 ( Suppl 1 ) : $5-$20.
6WHO report of the expert committeen diagnosis and classifica- tion of diabetes mellitus. Diabetes Care, 1997,20:1183-1197.
